版本:
中国

BRIEF-Loxo Oncology announces enrollment of first patient in phase 1 clinical trial of loxo-292

May 10 Loxo Oncology Inc:

* Loxo Oncology announces enrollment of first patient in phase 1 clinical trial for highly selective ret inhibitor, loxo-292 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐